Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.

Source:http://linkedlifedata.com/resource/pubmed/id/15676214

Download in:

View as

General Info

PMID
15676214